FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010213360> ?p ?o ?g. }

• W2010213360 endingPage "1229" @default.
• W2010213360 startingPage "1217" @default.
• W2010213360 abstract "Background: Since the 1990s a multitude of statin trials have definitively demonstrated the ability of statin therapy to reduce the risk of adverse coronary heart disease (CHD) events. Among these, the Atorvastatin Landmarks program – a group of 32 major atorvastatin trials – has assessed the efficacy and safety of atorvastatin across its full dose range and has helped illustrate its effectiveness in treatment of cardiovascular disease and its related disorders and also in non-cardiovascular outcomes.Scope: This paper will review the major atorvastatin clinical trials and report the important findings and their clinical significance.Findings: Clinical trials with atorvastatin have established significant reductions in cardiovascular events in patients with and without CHD. Studies show that high-dose atorvastatin will reduce LDL to ≈ 70 mg/dL in many patients and improve cardiac outcomes. Current evidence suggests that high-dose atorvastatin can halt and, in some cases, reverse atherosclerotic progression. A study of diabetic patients showed atorvastatin decreased the occurrence of acute CHD events, coronary revascularizations, and stroke. Atorvastatin has been found to be effective for reducing nonfatal myocardial infarctions and fatal CHD in hypertensive patients with three or more additional risk factors. High-dose atorvastatin was found to be effective in reducing risk of recurrent stroke in patients with prior cerebrovascular events, has been shown to benefit patients suffering a recent acute coronary syndrome, and to slow cognitive decline in preliminary studies of patients with Alzheimer's disease. Atorvastatin has been associated with reduced progression of mild chronic kidney disease; however, in a randomized trial of patients with end stage renal disease on hemodialysis, atorvastatin showed no statistically significant benefit. Limitations of this review include lack of generalizablity of the atorvastatin trial data to other statins, lack of head to head outcome trials involving the newer more potent statins, and the relatively short study durations (none exceeded 5 years) when atherosclerosis is typically a decades-long disease.Conclusion: A compelling body of evidence documents that atorvastatin reduces major cardiovascular events in both secondary and primary prevention of CHD and in a broad range of patients and disease conditions. Furthermore, throughout its dose range, atorvastatin is safe and well tolerated." @default.
• W2010213360 created "2016-06-24" @default.
• W2010213360 creator A5001820251 @default.
• W2010213360 creator A5024111381 @default.
• W2010213360 creator A5031156257 @default.
• W2010213360 date "2008-03-20" @default.
• W2010213360 modified "2023-10-14" @default.
• W2010213360 title "Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin" @default.
• W2010213360 cites W1484156179 @default.
• W2010213360 cites W1601584293 @default.
• W2010213360 cites W1922625321 @default.
• W2010213360 cites W1966817707 @default.
• W2010213360 cites W1982982654 @default.
• W2010213360 cites W1987356421 @default.
• W2010213360 cites W1998391689 @default.
• W2010213360 cites W2001331398 @default.
• W2010213360 cites W2004034044 @default.
• W2010213360 cites W2009974662 @default.
• W2010213360 cites W2010162661 @default.
• W2010213360 cites W2014263073 @default.
• W2010213360 cites W2024674799 @default.
• W2010213360 cites W2027441714 @default.
• W2010213360 cites W2031185570 @default.
• W2010213360 cites W2034776223 @default.
• W2010213360 cites W2036773140 @default.
• W2010213360 cites W2040155238 @default.
• W2010213360 cites W2041074255 @default.
• W2010213360 cites W2043253248 @default.
• W2010213360 cites W2048532926 @default.
• W2010213360 cites W2051922899 @default.
• W2010213360 cites W2057542355 @default.
• W2010213360 cites W2057674977 @default.
• W2010213360 cites W2060709766 @default.
• W2010213360 cites W2065618165 @default.
• W2010213360 cites W2069557124 @default.
• W2010213360 cites W2078919468 @default.
• W2010213360 cites W2080056609 @default.
• W2010213360 cites W2080585365 @default.
• W2010213360 cites W2086023505 @default.
• W2010213360 cites W2088935147 @default.
• W2010213360 cites W2100676360 @default.
• W2010213360 cites W2100800328 @default.
• W2010213360 cites W2103477598 @default.
• W2010213360 cites W2107295258 @default.
• W2010213360 cites W2110601215 @default.
• W2010213360 cites W2112668155 @default.
• W2010213360 cites W2114027342 @default.
• W2010213360 cites W2114977104 @default.
• W2010213360 cites W2122146058 @default.
• W2010213360 cites W2124386131 @default.
• W2010213360 cites W2126563293 @default.
• W2010213360 cites W2131276314 @default.
• W2010213360 cites W2133140132 @default.
• W2010213360 cites W2136628642 @default.
• W2010213360 cites W2138987299 @default.
• W2010213360 cites W2139168645 @default.
• W2010213360 cites W2143833093 @default.
• W2010213360 cites W2145632027 @default.
• W2010213360 cites W2147346175 @default.
• W2010213360 cites W2155270329 @default.
• W2010213360 cites W2155598961 @default.
• W2010213360 cites W2157857368 @default.
• W2010213360 cites W2159449551 @default.
• W2010213360 cites W2160152341 @default.
• W2010213360 cites W2160390128 @default.
• W2010213360 cites W2166202023 @default.
• W2010213360 cites W2166910397 @default.
• W2010213360 cites W2175592470 @default.
• W2010213360 cites W2315638360 @default.
• W2010213360 cites W4238251256 @default.
• W2010213360 doi "https://doi.org/10.1185/030079908x292001" @default.
• W2010213360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18358084" @default.
• W2010213360 hasPublicationYear "2008" @default.
• W2010213360 type Work @default.
• W2010213360 sameAs 2010213360 @default.
• W2010213360 citedByCount "30" @default.
• W2010213360 countsByYear W20102133602013 @default.
• W2010213360 countsByYear W20102133602014 @default.
• W2010213360 countsByYear W20102133602015 @default.
• W2010213360 countsByYear W20102133602017 @default.
• W2010213360 countsByYear W20102133602018 @default.
• W2010213360 countsByYear W20102133602021 @default.
• W2010213360 countsByYear W20102133602022 @default.
• W2010213360 countsByYear W20102133602023 @default.
• W2010213360 crossrefType "journal-article" @default.
• W2010213360 hasAuthorship W2010213360A5001820251 @default.
• W2010213360 hasAuthorship W2010213360A5024111381 @default.
• W2010213360 hasAuthorship W2010213360A5031156257 @default.
• W2010213360 hasConcept C126322002 @default.
• W2010213360 hasConcept C127413603 @default.
• W2010213360 hasConcept C164705383 @default.
• W2010213360 hasConcept C168563851 @default.
• W2010213360 hasConcept C2776839432 @default.
• W2010213360 hasConcept C2777482532 @default.
• W2010213360 hasConcept C2777698277 @default.
• W2010213360 hasConcept C2780645631 @default.
• W2010213360 hasConcept C500558357 @default.
• W2010213360 hasConcept C535046627 @default.

• next